BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 31571303)

  • 1. Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network.
    Ciccarone M; Hohaus S; Pulsoni A; Cavaceppi P; Franzò S; Fabbri R; Cudillo L; Battistini R; Di Rocco A; Annibali O; Cox MC; Provenzano I; Abruzzese E; Renzi D; Tesei C; Anticoli Borza P; Cuccaro A; Andriani A; D'Elia GM; Facchiano A; Marchetti P; Cantonetti M
    Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13174. PubMed ID: 31571303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
    Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
    Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility preservation in childhood and adolescent female tumor survivors.
    Filippi F; Meazza C; Somigliana E; Podda M; Dallagiovanna C; Massimino M; Raspagliesi F; Terenziani M
    Fertil Steril; 2021 Oct; 116(4):1087-1095. PubMed ID: 34238574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments.
    Oktay K; Bedoschi G
    J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):342-6. PubMed ID: 25214440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility preservation in Turner syndrome: Karyotype does not predict ovarian response to stimulation.
    Vergier J; Bottin P; Saias J; Reynaud R; Guillemain C; Courbiere B
    Clin Endocrinol (Oxf); 2019 Nov; 91(5):646-651. PubMed ID: 31420888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility Preservation in Breast Cancer.
    O'Donoghue C; Quinn GP; Lee MC
    South Med J; 2017 Oct; 110(10):621-626. PubMed ID: 28973701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study.
    Badawy A; Elnashar A; El-Ashry M; Shahat M
    Fertil Steril; 2009 Mar; 91(3):694-7. PubMed ID: 18675959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
    Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
    Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian response to stimulation for fertility preservation in women with hematologic cancer.
    Brun T; Dion L; Jaillard S; Bales D; Domin M; Lavoué V; Levêque J; Houot R; Duros S
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101925. PubMed ID: 33010467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
    Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists.
    Hickman LC; Valentine LN; Falcone T
    Am J Obstet Gynecol; 2016 Oct; 215(4):415-22. PubMed ID: 27422055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oocyte cryopreservation after controlled ovarian hyperstimulation in mosaic Turner syndrome: another fertility preservation option in a dedicated UK clinic.
    El-Shawarby SA; Sharif F; Conway G; Serhal P; Davies M
    BJOG; 2010 Jan; 117(2):234-7. PubMed ID: 20002398
    [No Abstract]   [Full Text] [Related]  

  • 13. DuoStim: a new option for fertility preservation for a woman with Turner syndrome.
    Ito A; Katagiri Y; Tamaki Y; Fukuda Y; Oji A; Morita M
    Gynecol Endocrinol; 2020 Dec; 36(12):1144-1148. PubMed ID: 32945708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment.
    Janse F; Donnez J; Anckaert E; de Jong FH; Fauser BC; Dolmans MM
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1136-44. PubMed ID: 21289248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility preservation options in breast cancer patients.
    Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
    Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).
    Choi MC; Chung YS; Lee JW; Kwon BS; Park BK; Kim SI; Shim SH; Lee KB; Seong SJ; Lee SJ; Lee SH; Yoo HJ; Song T; Kim MK; Baek MH; Kang S; Kim YM
    Eur J Cancer; 2020 Jul; 133():56-65. PubMed ID: 32442924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian damage from chemotherapy and current approaches to its protection.
    Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
    Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for fertility preservation in young early breast cancer patients.
    Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
    Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
    Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
    Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.